Ophthalmologic Manifestation of Behçet's Disease

Yonsei Medical Journal

Volumn 38, Issue 6, 1997, Pages 390-394

  Kim, Hong Bok ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Beh et's disease; Iridocyclitis; Occlusive retinitis

Indexed keywords

BEHCET DISEASE; EYE; HUMAN; PATHOLOGY; PROGNOSIS; REVIEW; BLINDNESS; CLINICAL FEATURE; IRIDOCYCLITIS; RELAPSE; REMISSION; RETINA VASCULITIS;

BEHCET SYNDROME; EYE; HUMANS; PROGNOSIS;

EID: 0031304010     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.1997.38.6.390     Document Type: Article

References (18)

1. Atmaca LS: Found change associated with Behçet's disease. Graefes Arch Clin Exp Ophthalmol 227: 340-344, 1989
2. Barra C, Belfort R, Abreu M: Behçet's disease in Brazil: a review of 49 cases with emphasis on ophthalmic manifestation. Jpn J Ophthalmol 35: 339-346, 1991
3. Benezra D, Cohen E: Treatment and visual prognosis in Behçet's disease. Br J Ophthalmol 70: 589-592, 1986
4. Benezra D, Cohen E, Chajek T: Evaluation of conventional therapy versus cyclosporin A in Bechet's syndrome. Transplant Proc 20(suppl 4): 143-146, 1988
5. Choi YS, Chung H: Clinical manifestation and visual prognosis in Behçet's disease. J Korean Ophthalmol Soc 36: 1514-1521, 1995
6. Durand JM, Soubeyrand J: Interferon-alpha 2B for refractory ocular Behçet's disease [letter]. Lancet 344: 333, 1994
7. Fenton RM, Easom HA: Behçet's syndrome : a histopathologic study of the eye. Arch Ophthalmol 72: 71-81, 1964
8. Foster CS, Baer JC, Raizman MB: Therapeutic responses to systermic immunosuppressive chemotheraphy in patients with Behçet's syndrome affecting the eyes, In O'Duffy JD, Kokman E, eds. Behçet's disease: basic and clinical aspects. New York, Marcel Dekker, 581-588, 1991
9. Kang SJ, Kim HB: Behçet's disease in Korean. J Korean Ophthalmol Soc 33: 332-341, 1992
10. Kim HB, Kim EK, Park K, Chung H: Results of Cyclosporin A therapy in Behçet's disease. J Korean Ophthalmol Soc 31: 469-475, 1990
11. Mamo JG: The rate of visual loss in Behçet's disease. Arch Ophthalmol 84: 451-452, 1970
12. Michelson JB, Chisari FV: Behçet's disease. Surv Ophthalmol 26: 190-203, 1982
13. Mishima S, Masuda K, Izawa Y, Mochizuki M: Behçet's disease in Japan: Ophthalmologic aspects. Trans Am Ophthalmol Soc 77: 225-233, 1979
14. Nussenblatt RB, Palestine AG, Chan CC, Mochizuki M, Yancey K: Effectiveness of cyclosporine therapy for Behçet's disease. Arthritis Rheum 28: 671-679, 1985
15. Oshima Y, Shimizu T, Yokohari R: Clinical studies on Behçet's syndrome. Ann Rheum Dis 22: 36-45, 1963
16. Palestine AG, Austin HA III, Balow JE, Antonovuck TT, Sabnis SG, Preus HG, Nussenblatt RB: Renal histopathologic alterations in patients treated with Cyclosporine for uveitis. N Engl J Med 314: 1293-1298, 1986
17. Raizman MB, Foster CS: Plasma exchange in the theraphy of Behçet's disease. Graefes Arch Clin Exp Ophthalmol 227: 360-363, 1989
18. Yazici H, Pazarli H, Barnes CG: A controlled trial of azathioprine in Behçet's syndrome. N Engl J Med 322: 281-285, 1990